High plasma concentration of remnant lipoprotein cholesterol in obese children and adolescents

Diabetes Care

Volumn 29, Issue 10, 2006, Pages 2305-2310

  Yong, Jun Choi ^a   Young, Eun Jo ^a   Yun, Kyung Kim ^a   Sang, Mi Ahn ^a   Sun, Hye Jung ^a   Hae, Jin Kim ^a   Chung, Yoon Sok ^a   Kwan, Woo Lee ^a   Dae, Jung Kim ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN AI ANTIBODY; APOLIPOPROTEIN B 100 ANTIBODY; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN ANTIBODY; REMNANT LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL FAT; ADOLESCENT; ANTIBODY AFFINITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY FAT DISTRIBUTION; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GEL; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; OBESITY; SCHOOL CHILD; SUBCUTANEOUS FAT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ABDOMINAL FAT; ADOLESCENT; APOLIPOPROTEIN B-100; BLOOD PRESSURE; BODY MASS INDEX; CHILD; CHOLESTEROL, VLDL; FEMALE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; KOREA; MALE; MULTIVARIATE ANALYSIS; OBESITY; SUBCUTANEOUS FAT; TRIGLYCERIDES;

EID: 33845444106     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-0938     Document Type: Article

References (34)

1. Seman LJ, McNamara JR, Schaefer EJ: Lipoprotein(a), homocysteine, and remnant-like particles: emerging risk factors. Curr Opin Cardiol 14:186 -191, 1999
2. Havel RJ: Remnant lipoproteins as therapeutic targets. Curr Opin Lipidol 11:615-620, 2000
3. Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M, Tanaka A, Tada N, Nakamura H, Campos E, Havel RJ: Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels. Clin Chim Acta 223:53-71, 1993
4. McNamara JR, Shah PK, Nakajima K, Cupples LA, Wilson PW, Ordovas JM, Schaefer EJ: Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study. Atherosclerosis 154:229-236, 2001
5. Kugiyama K, Doi H, Takazoe K, Kawano H, Soejima H, Mizuno Y, Tsunoda R, Sakamoto T, Nakano T, Nakajima K, Ogawa H, Sugiyama S, Yoshimura M, Yasue H: Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation 99:2858-2860, 1999
6. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM: Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 291:2847-2850, 2004
7. Kim DM, Ahn CW, Nam SY: Prevalence of obesity in Korea. Obes Rev 6:117-121, 2005
8. Dietz WH: Health consequences of obesity in youth: childhood predictors of adulthood disease (Review). Pediatrics 101:518-525, 1998
9. Becque MD, Katch VL, Rocchini AP, Marks CR, Moorehead C: Coronary risk incidence of obese adolescents: reduction by exercise plus diet intervention. Pediatrics 81:605- 612, 1988
10. Cresanta JL, Burke GL, Downey AM, Freedman DS, Berenson GS: Prevention of atherosclerosis in childhood. Pediatr Clin North Am 33:853- 858, 1986
11. Srinivasan SR, Berenson GS: Childhood lipoprotein profiles and implications for adult coronary artery disease: the Bogalusa Heart Study. Am J Med Sci 310(Suppl. 1):S62-S67, 1995
12. Weiss R, Caprio S: The metabolic consequences of childhood obesity. Best Pract Res Clin Endocrinol Metab 19:405- 419, 2005
13. Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R, Grummer-Strawn LM, Curtin LR, Roche AF, Johnson CL: Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 109:45- 60, 2002
14. Park HS, Han JH, Choi KM, Kim SM: Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents. Am J Clin Nutr 82:1046-1051, 2005
15. Daniels SR, Khoury PR, Morrison JA: The utility of body mass index as a measure of body fatness in children and adolescents: differences by race and gender. Pediatrics 99:804-807,1997
16. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, Lang CC, Rumboldt Z, Onen CL, Lisheng L, Tanomsuo S, Wanjai P Jr, Razak F, Sharma AM, Anand S: Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366:1640-1649, 2005
17. Brambilla P, Manzoni P, Sironi S, Simone P, Del Maschio A, di Natale B, Chiumello G: Peripheral and abdominal adiposity in childhood obesity. Int J Obes Relat Metab Disord 18:795-800,1994
18. Artz E, Ha A, Freemark M: Hormonal and metabolic consequences of childhood obesity. Endocrinol Metab Clin North Am 34:643- 658, 2005
19. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F: Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation 97:1029-1036, 1998
20. Eberly LE, Stamler J, Neaton JD, the Multiple Risk Factor Intervention Trial Research Group: Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease. Arch Intern Med 163:1077-1083, 2003
21. Sakata K, Miho N, Shirotani M, Yoshida H, Takada Y, Takada A: Remnant-like particle cholesterol is a major risk factor for myocardial infarction in vasospastic angina with nearly normal coronary artery. Atherosclerosis 136:225-231, 1998
22. Tomono S, Kawazu S, Kato N, Ono T, Ishii C, Ito Y, Shimizu M, Shimoyama M, Nakano T, Nakajima K: Uptake of remnant like particles (RLP) in diabetic patients from mouse peritoneal macrophages. J Atheroscler Thromb 1:98 -102, 1994
23. Saniabadi AR, Umemura K, Shimoyama M, Adachi M, Nakano M, Nakashima M: Aggregation of human blood platelets by remnant like lipoprotein particles of plasma chylomicrons and very low density lipoproteins. Thromb Haemost 77:996-1001, 1997
24. Kawakami A, Tanaka A, Nakajima K, Shimokado K, Yoshida M: Atorvastatin attenuates remnant lipoprotein-induced monocyte adhesion to vascular endothelium under flow conditions. Circ Res 91:263-271, 2002
25. Masuoka H, Kamei S, Wagayama H, Ozaki M, Kawasaki A, Tanaka T, Kitamura M, Katoh S, Shintani U, Misaki M, Sugawa M, Ito M, Nakano T: Association of remnant-like particle cholesterol with coronary artery disease in patients with normal total cholesterol levels. Am Heart J 139:305-310, 2000
26. Fukushima H, Kugiyama K, Sugiyama S, Honda O, Koide S, Nakamura S, Kawano H, Soejima H, Miyamoto S, Yoshimura M, Sakamoto T, Ogawa H: Comparison of remnant-like lipoprotein particles in postmenopausal women with and without coronary artery disease and in men with coronary artery disease. Am J Cardiol 88:1370-1373, 2001
27. Satoh A, Adachi H, Tsuruta M, Hirai Y, Hiratsuka A, Enomoto M, Furuki K, Hino A, Takeuchi T, Imaizumi T: High plasma level of remnant-like particle cholesterol in the metabolic syndrome. Diabetes Care 28:2514-2518, 2005
28. Akuzawa K, Nakano T, Sekiguchi I, Shimoyama M, Adachi M, Tange S, Tanaka A, Tada N, Nakajima K: [Remnant-like particles-cholesterol (RLP cholesterol) assay and its clinical application to lipid tests in a postprandial as well as fasting state]. Jpn J Clin Pathol 43:1159-1167, 1995 (in Japanese)
29. Slyper AH: Childhood obesity, adipose tissue distribution, and the pediatric practitioner. Pediatrics 102:e4,1998
30. De Ridder CM, de Boer RW, Seidell JC, Nieuwenhoff CM, Jeneson JA, Bakker CJ, Zonderland ML, Erich WB: Body fat distribution in pubertal girls quantified by magnetic resonance imaging. Int J Obes Relat Metab Disord 16:443-449,1992
31. Imke C, Rodriguez BL, Grove JS, McNamara JR, Waslien C, Katz AR, Willcox B, Yano K, Curb JD: Are remnant-like particles independent predictors of coronary heart disease incidence? The Honolulu Heart Study. Arteriocler Thromb Vasc Biol 25:1718-1722, 2005
32. Watanabe N, Taniguchi T, Taketoh H, Kitagawa Y, Namura H, Yoneda N, Kurimoto Y, Yamada S, Ishikawa Y: Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients. Diabetes Care 22:152-156, 1999
33. Ohnishi H, Saitoh S, Takagi S, Ohata J, Isobe T, Kikuchi Y, Takeuchi H, Shimamoto K: Relationship between insulin-resistance and remnant-like particle cholesterol. Atherosclerosis 164:167-170, 2002
34. Taskinen MR: Diabetic dyslipidemia: from basic research to clinical practice. Diabetologia 46:733-749, 2003